Delphinus SoftVue Prospective Case Collection - ARM 2
NCT02977247 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1150
Last updated 2021-09-05
Summary
The SoftVue™ is a whole breast ultrasound system with an automated scanning curvilinear ring-array transducer that employs UST. It is currently cleared under FDA 510(k) K123209 and K142517 for use as both a B-mode ultrasonic breast imaging system and color imaging of transmission data (sound speed and attenuation). SoftVue™ is not intended to be used as a replacement for screening mammography.
SoftVue uses non-ionizing ultrasound energy to generate tomographic image volumes of the whole breast. While the patient lays prone on a padded table with one breast comfortably submerged in a bath of warm water, a ring-shaped transducer, 22 cm in diameter, encircles the breast and pulses low-frequency sound waves through the water and into the breast tissue. More than 2000 elements in the curvilinear transducer's 360 degree array emit and receive ultrasound signals to analyze echoes from the breast anatomy in all directions, from the chest wall to the nipple. Not only does SoftVue capture data from the reflection of the sound waves off of tissue boundaries and structures within the breast, but because the transducer surrounds the whole breast, SoftVue also captures signals that are transmitted through the breast. This additional transmission data enhances the visualization of the anatomic structure of the breast tissue and is not currently available in any other commercially marketed breast ultrasound device.
This prospective, multicenter, multi-arm, clinical case collection program is IRB-approved and will be conducted in compliance with Good Clinical Practice, the Declaration of Helsinki and all applicable regulatory requirements. Arm 2 aims to collectively enroll up to 1,000 women at a total of up to 8 clinical sites. The design of Arm 2 in this protocol is strictly limited to case collection and is non-interventional; any investigational and/or statistical plans for future analyses will be prepared and registered separately, if they are applicable to the requirements of FDAAA 801.
Arm 2 is limited to the cohort of diagnostic female patients of any breast density composition category, who have been recommended for a breast biopsy (BI-RADS 4 or 5) after diagnostic imaging, or who have confirmed imaging findings. Matched sets of diagnostic imaging and SV exams, from the same patient, demographic information, and clinical outcome data, will be collected during diagnostic workup. Ultrasound characteristics for all types of lesions, whether they are benign or malignant, will be collected as well as objective and subjective breast density composition data. Ultrasound image data may be acquired with modified SoftVue devices, which have passed safety and quality evaluations per Delphinus' quality management system (QMS) and satisfy design change control standards, at select clinical sites in accordance with 21 CFR 812.2 (b), as a routine part of feasibility, validation, and verification testing for engineering and product development purposes.
The exams and clinical data accumulated in this prospective case collection (PCC) protocol will populate a database from which future investigations may be designed for peer reviewed publication, development of user training curricula, building teaching case, and creating new marketing materials for SoftVue.
Conditions
- Breast Neoplasms
Interventions
- OTHER
-
Non-Interventional
Only standard care procedures will be performed for clinical intervention and diagnostic purposes.
- DEVICE
-
Automated Whole Breast Ultrasound
Bilateral breast ultrasound images will be captured, but not clinically evaluated for diagnostic purposes by a physician.
Sponsors & Collaborators
-
Delphinus Medical Technologies, Inc.
lead INDUSTRY
Principal Investigators
-
Mary W Yamashita, MD · Keck School of Medicine, University of Southern California
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-12-06
- Primary Completion
- 2019-10-31
- Completion
- 2021-07-31
Countries
- United States
Study Locations
More Related Trials
-
3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast Cancer
NCT05704283 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Diagnosing Obstructive Lung Disease With Point of Care Ultrasound
NCT06251271 ·Status: COMPLETED
-
Feasibility Study of the Microwave Ablation System for Lung Tissue Ablation
NCT06158971 ·Status: RECRUITING ·Phase: NA
-
A Study Assessing the Safety and Utility of PINPOINT® Near Infrared Fluorescence Imaging in the Identification of Lymph Nodes in Patients With Uterine and Cervical Malignancies Who Are Undergoing Lymph Node Mapping
NCT02209532 ·Status: COMPLETED ·Phase: NA
-
Noninvasive Assessment of Lymphedema Among Breast Cancer Survivors
NCT05278871 ·Status: COMPLETED ·Phase: NA
-
Thin and Ultrathin Bronchoscopy With Transbronchial Needle Aspiration and Radial Probe Endobronchial Ultrasound for Peripheral Pulmonary Lesions
NCT04331587 ·Status: COMPLETED
-
Diagnostic Accuracy of Handheld vs Traditional Ultrasound
NCT05196776 ·Status: COMPLETED ·Phase: NA
-
Real-Time Contrast-Enhanced Ultrasonography and Shear Wave Elastography in Predicting Treatment Response in Patients With Soft Tissue Sarcoma
NCT02384473 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Safety and Effectiveness Study for a Needle Guidance System in Lung Biopsies
NCT01183182 ·Status: COMPLETED ·Phase: PHASE4
-
Thoracoscopic Lung Cancer Staging With the Use of Intraoperative Ultrasound
NCT02218242 ·Status: TERMINATED ·Phase: NA
-
Near Infrared Fluorescence Imaging With Indocyanine Green
NCT02851368 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Image - Navigated Resection of Lung Nodules
NCT04702165 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Respiration Gated Laser Guided CT Lung Nodule Biopsy
NCT01236937 ·Status: UNKNOWN ·Phase: NA
-
A Study of Multiparametric Ultrasound Imaging Methods
NCT07270237 ·Status: RECRUITING ·Phase: NA
-
Spectrum Analysis in Ex-vivo Human Lungs
NCT03356743 ·Status: COMPLETED ·Phase: NA
-
The Use of Artificial Intelligence to Predict Cancerous Lymph Nodes for Lung Cancer Staging During Ultrasound Imaging
NCT03849040 ·Status: COMPLETED
-
DOLPHIN-VIVO: Diagnosis Of LymPHoma IN Vivo (Ex Vivo Phase)
NCT04162431 ·Status: COMPLETED
-
Study Using Combined Virtual 4-D Electromagnetic (EM) Tip-Tracked Devices & EBUS in Diagnosis of Lung Nodules
NCT01947530 ·Status: COMPLETED ·Phase: NA
-
Beacon BNX™ Endoscopic Ultrasound (EUS)-Needle vs SharkCore™ Needle
NCT02872831 ·Status: WITHDRAWN ·Phase: NA
-
Feasibility of a Minimally Invasive Thoracoscopic Ultrasound for Localization of Pulmonary Nodules
NCT02665078 ·Status: COMPLETED
-
Thin-EBUS in Ex-vivo Human Lungs
NCT03349307 ·Status: COMPLETED ·Phase: NA
-
Novel Thin Bronchoscope Versus Ultrathin Bronchoscope for the Diagnosis of Peripheral Pulmonary Nodules
NCT07135297 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Electromagnetic Navigational Bronchoscopy Vs. Transthoracic Needle Biopsy for the Sampling of Peripheral Lung Nodules
NCT02651506 ·Status: WITHDRAWN ·Phase: PHASE2
-
Interest of Narrow Band Imaging in Detection of Upper Aerodigestive Cancers
NCT02035735 ·Status: COMPLETED ·Phase: NA
-
Cone Beam CT Guided Robotic Navigational Bronchoscopy
NCT05358041 ·Status: UNKNOWN